Literature DB >> 2613832

Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection.

J Moncrieff1.   

Abstract

Increased blood aldehyde levels, as occur in alcohol intoxication, could lead to the formation of beta-carbolines such as harmane by condensation with indoleamines. Endogenous beta-carbolines, therefore, should occur in specific brain areas where indoleamine concentrations are high, whilst exogenous beta-carbolines should exhibit an even distribution. The author presents direct and sensitive methods for assaying the beta-carbolines harmane, harmine and harmaline in brain tissue, cerebrospinal fluid and plasma at picogram sample concentrations using reversed-phase high-performance liquid chromatography with fluorimetric detection and minimal sample preparation. Using these assay methods, it was found that the distribution of beta-carbolines from a source exogenous to the brain results in a relatively even distribution within the brain tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613832     DOI: 10.1016/s0378-4347(00)82576-1

Source DB:  PubMed          Journal:  J Chromatogr


  12 in total

1.  Determination of harmane and harmine in human blood using reversed-phased high-performance liquid chromatography and fluorescence detection.

Authors:  W Zheng; S Wang; L F Barnes; Y Guan; E D Louis
Journal:  Anal Biochem       Date:  2000-03-15       Impact factor: 3.365

2.  Harmane inhibits serotonergic dorsal raphe neurons in the rat.

Authors:  Khalid Touiki; Pascal Rat; Robert Molimard; Abderrahman Chait; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Mary M Mullaney; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-08-11       Impact factor: 4.294

4.  Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors.

Authors:  I F Musgrave; E Badoer
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

5.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Amanda S Viner; Pam Factor-Litvak; Wei Zheng
Journal:  J Toxicol Environ Health A       Date:  2012

6.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain.

Authors:  Elan D Louis; Julian Benito-León; Sara Moreno-García; Saturio Vega; Juan Pablo Romero; Felix Bermejo-Pareja; Marina Gerbin; Amanda S Viner; Pam Factor-Litvak; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2012-09-12       Impact factor: 4.294

7.  Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Xinhua Liu; Jean-Paul G Vonsattel; Monika Galecki; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-08-02       Impact factor: 4.294

Review 8.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

9.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.

Authors:  Elan D Louis; Wendy Jiang; Kathryn M Pellegrino; Eileen Rios; Pam Factor-Litvak; Claire Henchcliffe; Wei Zheng
Journal:  Neurotoxicology       Date:  2007-12-27       Impact factor: 4.294

10.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.

Authors:  Elan D Louis; Monika Michalec; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-12-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.